Search results
The Zacks Analyst Blog Highlights J&J, Novartis, GSK, Merck and AbbVie
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 25, 2022 – Zacks.com announces the list of stocks featured...
Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
Zacks via Yahoo Finance· 8 months agoNovartis NVS completed the spin-off of its generic and biosimilar unit, Sandoz, following which...
Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 1 year agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Savvy Investors Plow Money Into These 10 Stocks And One IPO
Investor's Business Daily· 1 year agoMicrosoft, Paccar, Broadcom and Salesforce top this month's list of new buys by the best mutual...
Hot Biotech Play Breaks Out Into By Range
Investor's Business Daily· 5 months agoA mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. The SPDR S&P...
Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study
Zacks via Yahoo Finance· 1 year agoMerck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ)...
Weekly Upgrades and Downgrades
InvestorPlace via Yahoo Finance· 2 years agoDuring these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking...
